(R)-()-Aminoglutethimide
≥95%
- Product Code: 73950
CAS:
55511-44-9
| Molecular Weight: | 232.28 g./mol | Molecular Formula: | C₁₃H₁₆N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD03094025 | |
| Melting Point: | 115.5-119.5 °C (lit.) | Boiling Point: | 457.4±45.0 °C(Predicted) |
| Density: | 1.173±0.06 g/cm3(Predicted) | Storage Condition: | room temperature |
Product Description:
Used primarily in medical treatments, it acts as an inhibitor of aromatase, an enzyme crucial in the production of estrogens. This property makes it valuable in the management of hormone-dependent cancers, such as breast cancer, where reducing estrogen levels can help slow tumor growth. Additionally, it has been utilized in the treatment of Cushing's syndrome, a condition characterized by excessive cortisol production, by inhibiting steroidogenesis, the process by which steroids are produced from cholesterol. Its role in these therapeutic areas underscores its importance in endocrine-related disorders and oncological care.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Off-white Solid, Powder or Crystals |
| PURITY | 94.5-100 |
| Specific Rotation a20Dc1 in MeOH | 158.0 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €142.23 |
+
-
|
(R)-()-Aminoglutethimide
Used primarily in medical treatments, it acts as an inhibitor of aromatase, an enzyme crucial in the production of estrogens. This property makes it valuable in the management of hormone-dependent cancers, such as breast cancer, where reducing estrogen levels can help slow tumor growth. Additionally, it has been utilized in the treatment of Cushing's syndrome, a condition characterized by excessive cortisol production, by inhibiting steroidogenesis, the process by which steroids are produced from cholesterol. Its role in these therapeutic areas underscores its importance in endocrine-related disorders and oncological care.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :